BIT 2.94% 3.3¢ biotron limited

Ann: Letter to Shareholders, page-7

  1. 2,247 Posts.
    lightbulb Created with Sketch. 298
    Look at conclusion-Quote, development of a new drug is a long process.

    There are many competitor in the world and anyone may develop prior to BIT but who knows. Risks are involved and timeframe isn't known. Those who bought at 40c plus will have to wait for a long time before any productive outcome is approved and commercialised.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.3¢
Change
-0.001(2.94%)
Mkt cap ! $29.77M
Open High Low Value Volume
3.4¢ 3.5¢ 3.3¢ $8.412K 247.3K

Buyers (Bids)

No. Vol. Price($)
2 139827 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 76443 2
View Market Depth
Last trade - 15.43pm 17/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.